Bern, Get Ready (BEready) Cohort Study for Pandemic Preparedness
Launched by UNIVERSITY OF BERN · Dec 12, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The BEready study is looking to improve how people in the Canton of Bern can prepare for future pandemics. Researchers want to learn about how infections spread not just between people, but also between people and animals. They are interested in how different social and environmental factors might affect the chances of catching or spreading diseases. Additionally, the study aims to understand how households and their pets have been impacted by COVID-19.
If you live in Bern and have been there for most of the week, you might be eligible to join the study, especially if you can give your consent and have internet access. This includes adults, children aged 11 and older, and parents or guardians. Participants will share their experiences and perspectives related to the pandemic, and even pets from eligible households can be included with their owners' permission. By participating, you can help researchers gather important information that could improve pandemic preparedness for everyone in the future.
Gender
ALL
Eligibility criteria
- Inclusion criteria for adults and children:
- • Informed consent
- • Residence (average of more than 3 days/week) in a private household in the canton of Bern where at least one member aged 18 agreed to take part.
- • For adults, children aged 14 years or older, and parents/legal guardians: internet connection (Wi-Fi, fixed or on a mobile phone) and personal email address.
- • For adults, children aged 11 years or older, and parents/legal guardians: able to understand, speak, read and write German, French and/or English.
- • Inclusion criteria for household pets: Pets of eligible household members with the consent of their owners.
- • Exclusion criteria for adults and children: Currently planned move outside the canton of Bern
About University Of Bern
The University of Bern, a leading research institution in Switzerland, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university fosters an environment where scientific inquiry and clinical application intersect. Its commitment to ethical standards and patient safety ensures that all trials are conducted with the highest integrity, striving to contribute valuable insights to the global medical community. The University of Bern actively engages in diverse therapeutic areas, aiming to translate research findings into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, , Switzerland
Patients applied
Trial Officials
Nicola Low, Prof. Dr. med.
Principal Investigator
University of Bern
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported